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Introduction
Most follow-up studies of patients treated by thyroidectomy make reference to the incidence of recurrence of thyrotoxicosis after operation. The prognosis for such relapsed patients with reference to subsequent morbidity and to the effectiveness of subsequent treatment is, however, uncertain. This study describes the results of treatment in 90 patients who relapsed after thyroidectomy. In this situation the results of treatment by drugs and surgery are very different from those of treatment of the first episode.
Methods
Ninety patients (77 (85 6%) female and 13 (14 4%) male) who had been treated by thyroidectomy for thyrotoxicosis and who had subsequently relapsed were reviewed. The age distribution of the patients at the time of operation is shown in Table I . Sixty-one (68%) of the thyroidectomies had been performed in the Western Infirmary, Glasgow, and 29 (32%) in other hospitals. Thirty-three (36 7%) of the operations were performed before 1950, 43 (47 8%) during 1951-60, and 14 (15 5%) during 1961-6. The time of relapse of thyrotoxicosis following the initial operation is shown in Fig. 1 Eighty-three presented with symptoms of recurrence and seven were found to be thyrotoxic when 84 patients treated by thyroidectomy for thyrotoxicosis in the Western Infirmary were reviewed (Roy et al., 1967) . Fifty-four (65%) had had symptoms for less than one year, 10 (12%) for one to two years, and 5 (6%) for more than two years In 14 (17%) the duration of symptoms was uncertain. Fifteen (16 7%) of the patients had a family history of the disease, in four the affected relative was the mother, in one the father, in five a sister, in one a brother, in one a daughter, in two a paternal cousin, and in one a paternal grandmother. All the patients following recurrence attended the thyroid clinic at the Western Infirmary.
An empirical dosage prescription procedure as previously described by Crooks et al. (1960) was used when radioiodine was administered.
Assessment of Thyroid Status.-Thyroid status was assessed on clinical grounds (Wayne, 1960) and by laboratory tests, including standard radioiodine (1311) tests with 5-hour and 48-hour thyroidal uptake, estimation of plasma levels of proteinbound radioiodine (P.B. 131I) at 48 hours (Wayne, 1960) , the two-and-a-half-hour thyroidal radioiodine uptake and clearance and absolute uptake of iodine (A.I.U.) (Wayne et al., 1964) , estimation of the serum P.B. 1271, the resin uptake of '31I-labelled tri-iodothyronine, and the "free thyroxine" index (Clark and Horn, 1965 All subsequently relapsed, two within one year, three from one to two years, two from four to six years, and the remaining two from 6 to 10 years. One patient had a third operation, but after this had a further recurrence of thyrotoxicosis. Apart from the recurrence rate of 100% the incidence of complications was low. One developed a haematoma, one an abscess, and the patient who had three operations developed vocal cord paresis after the third operation. Following relapse three patients were treated with a full course of antithyroid drugs, after which all relapsed, and six Treceived radioiodine. Of these, three became hypothyroid. One patient had a second thyroidectomy following a full course of antithyroid drugs, and this patient also relapsed. Six of the 10 patients who relapsed after a second operation had a positive family history of thyroid disease compared with 16 7% in the whole group (P = 0001).
Antithyroid Drugs
After recurrence 17 patients were treated with antithyroid drugs for a minimum period of one year. Only two had remained euthyroid up to the time of follow-up (mean period euthyroid after stopping drugs 15 months). Fifteen relapsed. Of those who relapsed 11 were treated with radioiodine, one had a second operation, and three had a second course of drugs following which one again relapsed. At the time of review two patients were still receiving treatment. Nine of the 15 patients relapsed within three months and 12 within one year.
Radioiodine
Eighty-six patients received a therapeutic dose of radioiodine. Of these, 64 were treated immediately after the first recurrence, 12 following failure of treatment with antithyroid drugs, and 10 following recurrence after a second thyroidectomy. Fiftyone patients (59-3%) required only one dose of radioiodine, 19 (214%) received two doses, 10 (11-6%) received threedoses,and 6 (7-7%) required more than three doses. The dose in mCi administered and the distribution of hypothyroidism are shown in Table II Thirty-six (54 7%) patients treated with radioiodine following the first thyroidectomy became hypothyroid compared with 5 (50%) of the 10 patients treated with 3l'I after a second thyroidectomy and 6 (50%) of the 12 patients treated by 131I after a full course of antithyroid drugs.
The test results confirming recurrent episodes of toxicity are shown in Table III , and are compared with a group of patients who remained euthyroid after thyroidectomy (Roy et al., 1967) . Thyroid uptake measurements at 5 hours (Fig. 3) , the plasma P.B. ':"I (Fig. 4) , and the serum P.B. 127I (Fig. 5) The P.B.I. of 43 patients in whom the diagnosis of hypothyroidism was confirmed by P.B. 127I was 2 03 +0-13 (S.E.M.), the T, resin uptake and " free thyroxine " index estimated in 14 patients were 25-9±0 86 and 1 7+0 26 respectively. 
Discussion
The time of recurrence of thyrotoxicosis after thyroidectomy contrasts with the time of recurrence after cessation of antithyroid drugs. In the present series only 17 % of those relapsing after treatment of thyrotoxicosis by thyroidectomy did so within the first year, compared with 70 % of patients relapsing after antithyroid drugs (Hershman et al., 1966 ). Cattell et al. (1952 reported that 19 (76%) of 25 patients whose thyrotoxicosis recurred after operation experienced the recurrence within three years of the initial operation. This supported the then current view that if patients remained symptom-free for a period of five years following operation, only a rare instance of recurrence would be found subsequently. In the present study only 54-5% of patients relapsed within five years after thyroidectomy. Hayles et at. (1959) reported that three patients had a recurrence more than 25 years after thyroidectomy. Douglas and Kennie (1952) considered that relapse after thyroidectomy is usually relatively mild. This, however, is not confirmed by the present series, since the results of treatment by both reoperation and antithyroid drugs were unsatisfactory. Recently another patient, not included in the present series, has been referred for treatment following relapse after three thyroidectomies. Recurrence after a second operation was not related to one operator, as the operations were performed by six different surgeons. In view of the high incidence of relapse Cattell et al. (1952) recommended a more radical excision of remnants. Taylor and Painter (1962) showed that of 43 thyrotoxic patients treated by partial thyroidectomy the two who relapsed within a year had larger volumes of thyroid tissue left at operation than those who remained euthyroid. This study suggests that there is a group of patients with hyperthyroidism in whom thyroidectomy is not the treatment of choice. Moreover, a second operation is also not without risk, and Riddell (1965) regards such a procedure as "the cardinal folly" because of the high incidence of complications which is likely to ensue. In the present series one patient developed a recurrent laryngeal nerve palsy after a third operation.
Antithyroid drugs would also appear from the present series to be unsatisfactory in the treatment of recurrent thyrotoxicosis. Solomon et al. (1953) , in reviewing data from eight clinics, found that the incidence of remission following cessation of antithyroid drug therapy was significantly greater for those patients with primary hyperthyroidism than for those with postoperative recurrence. Reveno and Rosenbaum (1964) , on the other hand, reported a favourable response to antithyroid drugs in patients with recurrent hyperthyroidism though the period of drug treatment required was longer. Hershman et al. (1966) found no significant difference in the incidence of remission in the two groups.
The results of treatment with radioiodine were more satisfactory and compared favourably with those reported by Green and Wilson (1964) , though the proportion requiring only one dose was less than that reported in other series (MacGregor, 1957; Blomfield et al., 1959; McGirr et al., 1964; Staffurth and Young, 1967) . Blomfield et al. (1959) found that the response to radioiodine was similar in patients with recurrent thyrotoxicosis and those with primary hyperthyroidism. The incidence of hypothyroidism would appear to be greater, since Greig (1966) reported an incidence of 41 % in patients followed up for one to eight years at this clinic. The incidence of hypothyroidism reported in other series is also lower (Beling and Einhorn, 1961 ; Green and Wilson, 1964 ; Dunn and Chapman, 1964; McGirr et al., 1964) , though Nofal et al. (1966) reported an incidence of 51 % in patients treated with radioiodine and followed for 1 to 16 years. Dunn and Chapman (1964) found that the incidence of hypothyroidism was significantly greater in those patients who had had a previous thyroidectomy. Sensitivity to radioiodine in patients with recurrent hyperthyroidism may be due in part to increased radiosensitivity and to difficulties in estimating the size of the thyroid remnant (Dunn and Chapman, 1964) . Radioiodine would appear to be the treatment of choice in patients who relapse after thyroidectomy provided that adequate follow-up is undertaken. In the present series those who did not receive 131I initially were subjected to prolonged periods of ill-health and fruitless treatment.
It has been shown that in euthyroid patients following thyroidectomy the P.B. 13 1I may be raised owing to a low intrathyroidal iodine pool, and the thyroidal radioiodine uptake may also be raised owing to a small extrathyroidal iodine pool (Koutras et al., 1961 ; Roy et al., 1967) . When the test results in the present series are compared with those in euthyroid patients after thyroidectomy (Roy et al., 1967) , the P.B. 131I provides poor separation between euthyroid and thyrotoxic patients. Thyroid uptake measurements at five hours and estimation of the serum P.B. 127I are, however, of greater value in diagnosing post-thyroidectomy recurrences.
Introduction
Since antithyroid drugs were first introduced numerous reports of their effectiveness have been published. Little attention, however, has been paid to the prognosis for those patients in whom thyrotoxicosis recurs after discontinuation of antithyroid drug therapy. In this study 130 thyrotoxic patients who relapsed after treatment with antithyroid drugs have been followed up.
Methods
Patients Studied.-The age and sex of the patients studied is shown in Table I . Of the 130 patients, 102 were treated initially in the Western Infirmary, Glasgow, and 28 in other hospitals. All had received antithyroid drugs for a minimum
